(Q43034724)

12 November 2017

title

Effect of alendronate on alveolar bone resorption and angiogenesis in rats with experimental periapical lesions (English)

1 reference

12 November 2017

H Xiong

1

1 reference

12 November 2017

L Wei

2

1 reference

12 November 2017

Y Hu

3

1 reference

12 November 2017

C Zhang

4

1 reference

12 November 2017

B Peng

5

1 reference

12 November 2017

publication date

1 June 2010

1 reference

International Endodontic Journal

12 November 2017

published in

1 reference

12 November 2017

volume

43

1 reference

12 November 2017

issue

6

1 reference

12 November 2017

page(s)

485-491

1 reference

Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors.

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2591.2010.01703.X

Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2591.2010.01703.X

Effects of risedronate on alveolar bone loss and angiogenesis: a stereologic study in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2591.2010.01703.X

Alendronate may protect against increased periodontitis-related bone loss in estrogen-deficient rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2591.2010.01703.X

The effect of surface immobilized bisphosphonates on the fixation of hydroxyapatite-coated titanium implants in ovariectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2591.2010.01703.X

Bisphosphonate administration prior to tooth extraction delays initial healing of the extraction socket in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2591.2010.01703.X

Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2591.2010.01703.X

Host-mediated resolution of inflammation in periodontal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2591.2010.01703.X

Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2591.2010.01703.X

Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2591.2010.01703.X

Skeletal bone diseases impact the periodontium: a review of bisphosphonate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2591.2010.01703.X

Molecular mechanisms of action of bisphosphonates: current status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2591.2010.01703.X

Osteonecrosis of the jaws and bisphosphonate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2591.2010.01703.X

The antineoplastic role of bisphosphonates: from basic research to clinical evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2591.2010.01703.X

Updates on bisphosphonates and potential pathobiology of bisphosphonate-induced jaw osteonecrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2591.2010.01703.X

Systemic and local ibandronate enhance screw fixation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2591.2010.01703.X

Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2591.2010.01703.X

Bisphosphonates and periodontics: potential applications for regulation of bone mass in the periodontium and other therapeutic/diagnostic uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2591.2010.01703.X

The effect of chemical inhibition of matrix metalloproteinases on the size of experimentally induced apical periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2591.2010.01703.X

Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2591.2010.01703.X

Osteonecrosis of the jaws associated with cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2591.2010.01703.X

Effect of an estrogen-deficient state and alendronate therapy on bone loss resulting from experimental periapical lesions in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2591.2010.01703.X

Immunolocalization of receptor activator of NF kappa B ligand in rat periapical lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2591.2010.01703.X

Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2591.2010.01703.X

10.1111/J.1365-2591.2010.01703.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference